カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト破傷風免疫グロブリン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Tetanus Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19399）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19399
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒト破傷風免疫グロブリン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒト破傷風免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト破傷風免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト破傷風免疫グロブリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・注射剤、凍結乾燥注射剤

用途別セグメントは次のように区分されます。
・破傷風予防、破傷風治療

世界のヒト破傷風免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。
・MassBiologics、BayTet、GC Biopharma、CSL Behring、Baxalta、CSL、Octapharma、LFB、Biotest、Kedrion、Hualan Biological Engineering、Beijing Tiantan Biological Products Co., Ltd、Shanghai Raas Blood Products Co. Ltd、China Biologic Products Holdings, Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト破傷風免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト破傷風免疫グロブリンメーカーの企業概要、2019年～2022年までのヒト破傷風免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト破傷風免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト破傷風免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト破傷風免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト破傷風免疫グロブリン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト破傷風免疫グロブリンの産業チェーンを掲載しています。
・第13、14、15章では、ヒト破傷風免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒト破傷風免疫グロブリンの概要
- 種類別分析（2017年vs2021年vs2028年）：注射剤、凍結乾燥注射剤
- 用途別分析（2017年vs2021年vs2028年）：破傷風予防、破傷風治療
- 世界のヒト破傷風免疫グロブリン市場規模・予測
- 世界のヒト破傷風免疫グロブリン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- MassBiologics、BayTet、GC Biopharma、CSL Behring、Baxalta、CSL、Octapharma、LFB、Biotest、Kedrion、Hualan Biological Engineering、Beijing Tiantan Biological Products Co., Ltd、Shanghai Raas Blood Products Co. Ltd、China Biologic Products Holdings, Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：注射剤、凍結乾燥注射剤
・用途別分析2017年-2028年：破傷風予防、破傷風治療
・ヒト破傷風免疫グロブリンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト破傷風免疫グロブリンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト破傷風免疫グロブリンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト破傷風免疫グロブリンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト破傷風免疫グロブリンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Tetanus Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Tetanus Immune Globulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Prevention of Tetanus accounting for % of the Human Tetanus Immune Globulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Tetanus Immune Globulin include MassBiologics, BayTet, GC Biopharma, CSL Behring, and Baxalta, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Tetanus Immune Globulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Freeze-dried Injection
Market segment by Application can be divided into
Prevention of Tetanus
Treatment of Tetanus
The key market players for global Human Tetanus Immune Globulin market are listed below:
MassBiologics
BayTet
GC Biopharma
CSL Behring
Baxalta
CSL
Octapharma
LFB
Biotest
Kedrion
Hualan Biological Engineering
Beijing Tiantan Biological Products Co., Ltd
Shanghai Raas Blood Products Co. Ltd
China Biologic Products Holdings, Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Tetanus Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Tetanus Immune Globulin, with price, sales, revenue and global market share of Human Tetanus Immune Globulin from 2019 to 2022.
Chapter 3, the Human Tetanus Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Tetanus Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Tetanus Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Tetanus Immune Globulin.
Chapter 13, 14, and 15, to describe Human Tetanus Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Tetanus Immune Globulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Tetanus Immune Globulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injection
1.2.3 Freeze-dried Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Tetanus Immune Globulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prevention of Tetanus
1.3.3 Treatment of Tetanus
1.4 Global Human Tetanus Immune Globulin Market Size & Forecast
1.4.1 Global Human Tetanus Immune Globulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Tetanus Immune Globulin Sales in Volume (2017-2028)
1.4.3 Global Human Tetanus Immune Globulin Price (2017-2028)
1.5 Global Human Tetanus Immune Globulin Production Capacity Analysis
1.5.1 Global Human Tetanus Immune Globulin Total Production Capacity (2017-2028)
1.5.2 Global Human Tetanus Immune Globulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Tetanus Immune Globulin Market Drivers
1.6.2 Human Tetanus Immune Globulin Market Restraints
1.6.3 Human Tetanus Immune Globulin Trends Analysis
2 Manufacturers Profiles
2.1 MassBiologics
2.1.1 MassBiologics Details
2.1.2 MassBiologics Major Business
2.1.3 MassBiologics Human Tetanus Immune Globulin Product and Services
2.1.4 MassBiologics Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BayTet
2.2.1 BayTet Details
2.2.2 BayTet Major Business
2.2.3 BayTet Human Tetanus Immune Globulin Product and Services
2.2.4 BayTet Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GC Biopharma
2.3.1 GC Biopharma Details
2.3.2 GC Biopharma Major Business
2.3.3 GC Biopharma Human Tetanus Immune Globulin Product and Services
2.3.4 GC Biopharma Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL Behring
2.4.1 CSL Behring Details
2.4.2 CSL Behring Major Business
2.4.3 CSL Behring Human Tetanus Immune Globulin Product and Services
2.4.4 CSL Behring Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Baxalta
2.5.1 Baxalta Details
2.5.2 Baxalta Major Business
2.5.3 Baxalta Human Tetanus Immune Globulin Product and Services
2.5.4 Baxalta Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Human Tetanus Immune Globulin Product and Services
2.6.4 CSL Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Octapharma
2.7.1 Octapharma Details
2.7.2 Octapharma Major Business
2.7.3 Octapharma Human Tetanus Immune Globulin Product and Services
2.7.4 Octapharma Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 LFB
2.8.1 LFB Details
2.8.2 LFB Major Business
2.8.3 LFB Human Tetanus Immune Globulin Product and Services
2.8.4 LFB Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biotest
2.9.1 Biotest Details
2.9.2 Biotest Major Business
2.9.3 Biotest Human Tetanus Immune Globulin Product and Services
2.9.4 Biotest Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Kedrion
2.10.1 Kedrion Details
2.10.2 Kedrion Major Business
2.10.3 Kedrion Human Tetanus Immune Globulin Product and Services
2.10.4 Kedrion Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hualan Biological Engineering
2.11.1 Hualan Biological Engineering Details
2.11.2 Hualan Biological Engineering Major Business
2.11.3 Hualan Biological Engineering Human Tetanus Immune Globulin Product and Services
2.11.4 Hualan Biological Engineering Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Beijing Tiantan Biological Products Co., Ltd
2.12.1 Beijing Tiantan Biological Products Co., Ltd Details
2.12.2 Beijing Tiantan Biological Products Co., Ltd Major Business
2.12.3 Beijing Tiantan Biological Products Co., Ltd Human Tetanus Immune Globulin Product and Services
2.12.4 Beijing Tiantan Biological Products Co., Ltd Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanghai Raas Blood Products Co. Ltd
2.13.1 Shanghai Raas Blood Products Co. Ltd Details
2.13.2 Shanghai Raas Blood Products Co. Ltd Major Business
2.13.3 Shanghai Raas Blood Products Co. Ltd Human Tetanus Immune Globulin Product and Services
2.13.4 Shanghai Raas Blood Products Co. Ltd Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 China Biologic Products Holdings, Inc
2.14.1 China Biologic Products Holdings, Inc Details
2.14.2 China Biologic Products Holdings, Inc Major Business
2.14.3 China Biologic Products Holdings, Inc Human Tetanus Immune Globulin Product and Services
2.14.4 China Biologic Products Holdings, Inc Human Tetanus Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Tetanus Immune Globulin Breakdown Data by Manufacturer
3.1 Global Human Tetanus Immune Globulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Tetanus Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Tetanus Immune Globulin
3.4 Market Concentration Rate
3.4.1 Top 3 Human Tetanus Immune Globulin Manufacturer Market Share in 2021
3.4.2 Top 6 Human Tetanus Immune Globulin Manufacturer Market Share in 2021
3.5 Global Human Tetanus Immune Globulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Tetanus Immune Globulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Tetanus Immune Globulin Market Size by Region
4.1.1 Global Human Tetanus Immune Globulin Sales in Volume by Region (2017-2028)
4.1.2 Global Human Tetanus Immune Globulin Revenue by Region (2017-2028)
4.2 North America Human Tetanus Immune Globulin Revenue (2017-2028)
4.3 Europe Human Tetanus Immune Globulin Revenue (2017-2028)
4.4 Asia-Pacific Human Tetanus Immune Globulin Revenue (2017-2028)
4.5 South America Human Tetanus Immune Globulin Revenue (2017-2028)
4.6 Middle East and Africa Human Tetanus Immune Globulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Tetanus Immune Globulin Sales in Volume by Type (2017-2028)
5.2 Global Human Tetanus Immune Globulin Revenue by Type (2017-2028)
5.3 Global Human Tetanus Immune Globulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Tetanus Immune Globulin Sales in Volume by Application (2017-2028)
6.2 Global Human Tetanus Immune Globulin Revenue by Application (2017-2028)
6.3 Global Human Tetanus Immune Globulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Tetanus Immune Globulin Sales by Type (2017-2028)
7.2 North America Human Tetanus Immune Globulin Sales by Application (2017-2028)
7.3 North America Human Tetanus Immune Globulin Market Size by Country
7.3.1 North America Human Tetanus Immune Globulin Sales in Volume by Country (2017-2028)
7.3.2 North America Human Tetanus Immune Globulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Tetanus Immune Globulin Sales by Type (2017-2028)
8.2 Europe Human Tetanus Immune Globulin Sales by Application (2017-2028)
8.3 Europe Human Tetanus Immune Globulin Market Size by Country
8.3.1 Europe Human Tetanus Immune Globulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Tetanus Immune Globulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Tetanus Immune Globulin Sales by Type (2017-2028)
9.2 Asia-Pacific Human Tetanus Immune Globulin Sales by Application (2017-2028)
9.3 Asia-Pacific Human Tetanus Immune Globulin Market Size by Region
9.3.1 Asia-Pacific Human Tetanus Immune Globulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Tetanus Immune Globulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Tetanus Immune Globulin Sales by Type (2017-2028)
10.2 South America Human Tetanus Immune Globulin Sales by Application (2017-2028)
10.3 South America Human Tetanus Immune Globulin Market Size by Country
10.3.1 South America Human Tetanus Immune Globulin Sales in Volume by Country (2017-2028)
10.3.2 South America Human Tetanus Immune Globulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Tetanus Immune Globulin Sales by Type (2017-2028)
11.2 Middle East & Africa Human Tetanus Immune Globulin Sales by Application (2017-2028)
11.3 Middle East & Africa Human Tetanus Immune Globulin Market Size by Country
11.3.1 Middle East & Africa Human Tetanus Immune Globulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Tetanus Immune Globulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Tetanus Immune Globulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Tetanus Immune Globulin
12.3 Human Tetanus Immune Globulin Production Process
12.4 Human Tetanus Immune Globulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Tetanus Immune Globulin Typical Distributors
13.3 Human Tetanus Immune Globulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Tetanus Immune Globulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Tetanus Immune Globulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 4. MassBiologics Major Business
Table 5. MassBiologics Human Tetanus Immune Globulin Product and Services
Table 6. MassBiologics Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BayTet Basic Information, Manufacturing Base and Competitors
Table 8. BayTet Major Business
Table 9. BayTet Human Tetanus Immune Globulin Product and Services
Table 10. BayTet Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GC Biopharma Basic Information, Manufacturing Base and Competitors
Table 12. GC Biopharma Major Business
Table 13. GC Biopharma Human Tetanus Immune Globulin Product and Services
Table 14. GC Biopharma Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 16. CSL Behring Major Business
Table 17. CSL Behring Human Tetanus Immune Globulin Product and Services
Table 18. CSL Behring Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Baxalta Basic Information, Manufacturing Base and Competitors
Table 20. Baxalta Major Business
Table 21. Baxalta Human Tetanus Immune Globulin Product and Services
Table 22. Baxalta Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. CSL Basic Information, Manufacturing Base and Competitors
Table 24. CSL Major Business
Table 25. CSL Human Tetanus Immune Globulin Product and Services
Table 26. CSL Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Octapharma Basic Information, Manufacturing Base and Competitors
Table 28. Octapharma Major Business
Table 29. Octapharma Human Tetanus Immune Globulin Product and Services
Table 30. Octapharma Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. LFB Basic Information, Manufacturing Base and Competitors
Table 32. LFB Major Business
Table 33. LFB Human Tetanus Immune Globulin Product and Services
Table 34. LFB Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biotest Basic Information, Manufacturing Base and Competitors
Table 36. Biotest Major Business
Table 37. Biotest Human Tetanus Immune Globulin Product and Services
Table 38. Biotest Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Kedrion Basic Information, Manufacturing Base and Competitors
Table 40. Kedrion Major Business
Table 41. Kedrion Human Tetanus Immune Globulin Product and Services
Table 42. Kedrion Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Biological Engineering Major Business
Table 45. Hualan Biological Engineering Human Tetanus Immune Globulin Product and Services
Table 46. Hualan Biological Engineering Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Beijing Tiantan Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Beijing Tiantan Biological Products Co., Ltd Major Business
Table 49. Beijing Tiantan Biological Products Co., Ltd Human Tetanus Immune Globulin Product and Services
Table 50. Beijing Tiantan Biological Products Co., Ltd Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Shanghai Raas Blood Products Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Shanghai Raas Blood Products Co. Ltd Major Business
Table 53. Shanghai Raas Blood Products Co. Ltd Human Tetanus Immune Globulin Product and Services
Table 54. Shanghai Raas Blood Products Co. Ltd Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. China Biologic Products Holdings, Inc Basic Information, Manufacturing Base and Competitors
Table 56. China Biologic Products Holdings, Inc Major Business
Table 57. China Biologic Products Holdings, Inc Human Tetanus Immune Globulin Product and Services
Table 58. China Biologic Products Holdings, Inc Human Tetanus Immune Globulin Sales (K Bottles), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Human Tetanus Immune Globulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Bottles)
Table 60. Global Human Tetanus Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Human Tetanus Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Human Tetanus Immune Globulin Production Capacity by Company, (K Bottles): 2020 VS 2021
Table 63. Head Office and Human Tetanus Immune Globulin Production Site of Key Manufacturer
Table 64. Human Tetanus Immune Globulin New Entrant and Capacity Expansion Plans
Table 65. Human Tetanus Immune Globulin Mergers & Acquisitions in the Past Five Years
Table 66. Global Human Tetanus Immune Globulin Sales by Region (2017-2022) & (K Bottles)
Table 67. Global Human Tetanus Immune Globulin Sales by Region (2023-2028) & (K Bottles)
Table 68. Global Human Tetanus Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Human Tetanus Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 71. Global Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 72. Global Human Tetanus Immune Globulin Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Human Tetanus Immune Globulin Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Human Tetanus Immune Globulin Price by Type (2017-2022) & (US$/Bottle)
Table 75. Global Human Tetanus Immune Globulin Price by Type (2023-2028) & (US$/Bottle)
Table 76. Global Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 77. Global Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 78. Global Human Tetanus Immune Globulin Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Human Tetanus Immune Globulin Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Human Tetanus Immune Globulin Price by Application (2017-2022) & (US$/Bottle)
Table 81. Global Human Tetanus Immune Globulin Price by Application (2023-2028) & (US$/Bottle)
Table 82. North America Human Tetanus Immune Globulin Sales by Country (2017-2022) & (K Bottles)
Table 83. North America Human Tetanus Immune Globulin Sales by Country (2023-2028) & (K Bottles)
Table 84. North America Human Tetanus Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Human Tetanus Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 87. North America Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 88. North America Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 89. North America Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 90. Europe Human Tetanus Immune Globulin Sales by Country (2017-2022) & (K Bottles)
Table 91. Europe Human Tetanus Immune Globulin Sales by Country (2023-2028) & (K Bottles)
Table 92. Europe Human Tetanus Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Human Tetanus Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 95. Europe Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 96. Europe Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 97. Europe Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 98. Asia-Pacific Human Tetanus Immune Globulin Sales by Region (2017-2022) & (K Bottles)
Table 99. Asia-Pacific Human Tetanus Immune Globulin Sales by Region (2023-2028) & (K Bottles)
Table 100. Asia-Pacific Human Tetanus Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Human Tetanus Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 103. Asia-Pacific Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 104. Asia-Pacific Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 105. Asia-Pacific Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 106. South America Human Tetanus Immune Globulin Sales by Country (2017-2022) & (K Bottles)
Table 107. South America Human Tetanus Immune Globulin Sales by Country (2023-2028) & (K Bottles)
Table 108. South America Human Tetanus Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Human Tetanus Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 111. South America Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 112. South America Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 113. South America Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 114. Middle East & Africa Human Tetanus Immune Globulin Sales by Region (2017-2022) & (K Bottles)
Table 115. Middle East & Africa Human Tetanus Immune Globulin Sales by Region (2023-2028) & (K Bottles)
Table 116. Middle East & Africa Human Tetanus Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Human Tetanus Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Human Tetanus Immune Globulin Sales by Type (2017-2022) & (K Bottles)
Table 119. Middle East & Africa Human Tetanus Immune Globulin Sales by Type (2023-2028) & (K Bottles)
Table 120. Middle East & Africa Human Tetanus Immune Globulin Sales by Application (2017-2022) & (K Bottles)
Table 121. Middle East & Africa Human Tetanus Immune Globulin Sales by Application (2023-2028) & (K Bottles)
Table 122. Human Tetanus Immune Globulin Raw Material
Table 123. Key Manufacturers of Human Tetanus Immune Globulin Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Human Tetanus Immune Globulin Typical Distributors
Table 127. Human Tetanus Immune Globulin Typical Customers
List of Figures
Figure 1. Human Tetanus Immune Globulin Picture
Figure 2. Global Human Tetanus Immune Globulin Revenue Market Share by Type in 2021
Figure 3. Injection
Figure 4. Freeze-dried Injection
Figure 5. Global Human Tetanus Immune Globulin Revenue Market Share by Application in 2021
Figure 6. Prevention of Tetanus
Figure 7. Treatment of Tetanus
Figure 8. Global Human Tetanus Immune Globulin Revenue, (USD Million) & (K Bottles): 2017 & 2021 & 2028
Figure 9. Global Human Tetanus Immune Globulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Human Tetanus Immune Globulin Sales (2017-2028) & (K Bottles)
Figure 11. Global Human Tetanus Immune Globulin Price (2017-2028) & (US$/Bottle)
Figure 12. Global Human Tetanus Immune Globulin Production Capacity (2017-2028) & (K Bottles)
Figure 13. Global Human Tetanus Immune Globulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Human Tetanus Immune Globulin Market Drivers
Figure 15. Human Tetanus Immune Globulin Market Restraints
Figure 16. Human Tetanus Immune Globulin Market Trends
Figure 17. Global Human Tetanus Immune Globulin Sales Market Share by Manufacturer in 2021
Figure 18. Global Human Tetanus Immune Globulin Revenue Market Share by Manufacturer in 2021
Figure 19. Human Tetanus Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Human Tetanus Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Human Tetanus Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Human Tetanus Immune Globulin Sales Market Share by Region (2017-2028)
Figure 23. Global Human Tetanus Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 24. North America Human Tetanus Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 25. Europe Human Tetanus Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Human Tetanus Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 27. South America Human Tetanus Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Human Tetanus Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 29. Global Human Tetanus Immune Globulin Sales Market Share by Type (2017-2028)
Figure 30. Global Human Tetanus Immune Globulin Revenue Market Share by Type (2017-2028)
Figure 31. Global Human Tetanus Immune Globulin Price by Type (2017-2028) & (US$/Bottle)
Figure 32. Global Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 33. Global Human Tetanus Immune Globulin Revenue Market Share by Application (2017-2028)
Figure 34. Global Human Tetanus Immune Globulin Price by Application (2017-2028) & (US$/Bottle)
Figure 35. North America Human Tetanus Immune Globulin Sales Market Share by Type (2017-2028)
Figure 36. North America Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 37. North America Human Tetanus Immune Globulin Sales Market Share by Country (2017-2028)
Figure 38. North America Human Tetanus Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 39. United States Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Human Tetanus Immune Globulin Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 44. Europe Human Tetanus Immune Globulin Sales Market Share by Country (2017-2028)
Figure 45. Europe Human Tetanus Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 46. Germany Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Human Tetanus Immune Globulin Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Human Tetanus Immune Globulin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Human Tetanus Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 55. China Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Human Tetanus Immune Globulin Sales Market Share by Type (2017-2028)
Figure 62. South America Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 63. South America Human Tetanus Immune Globulin Sales Market Share by Country (2017-2028)
Figure 64. South America Human Tetanus Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Human Tetanus Immune Globulin Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Human Tetanus Immune Globulin Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Human Tetanus Immune Globulin Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Human Tetanus Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Human Tetanus Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Human Tetanus Immune Globulin in 2021
Figure 76. Manufacturing Process Analysis of Human Tetanus Immune Globulin
Figure 77. Human Tetanus Immune Globulin Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト破傷風用免疫グロブリンのグローバル市場展望 2023年-2029年：注射剤、フリーズドライ注射剤
  • 世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）
  • 免疫グロブリン皮下注射のグローバル市場展望 2023年-2029年：2g、4g、10g、その他
  • 世界のハイパー免疫グロブリン市場2022年：市場規模予測（～2028年）
  • 世界の狂犬病免疫グロブリン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19399 )"世界のヒト破傷風免疫グロブリン市場2022年：市場規模予測（～2028年）" (英文：Global Human Tetanus Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。